These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1212261)

  • 1. Studies of the mechanism of action of the tumour-inhibitory nitrosoureas.
    Connors TA; Hare JR
    Biochem Pharmacol; 1975 Dec; 24(23):2133-40. PubMed ID: 1212261
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
    Eisenbrand G
    IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates.
    Baril BB; Baril EF; Laszlo J; Wheeler GP
    Cancer Res; 1975 Jan; 35(1):1-5. PubMed ID: 162855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of action of the tumour inhibitory triazenes.
    Audette RC; Connors TA; Mandel HG; Merai K; Ross WC
    Biochem Pharmacol; 1973 Aug; 22(15):1855-64. PubMed ID: 4722457
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antineoplastic nitrosoureas].
    Tang WC
    Yao Xue Xue Bao; 1982 Jun; 17(6):472-9. PubMed ID: 7148473
    [No Abstract]   [Full Text] [Related]  

  • 6. A new class of nitrosoureas. VI. Synthesis and antitumor activity of 3-substituted-1-(2-chloroethyl)-3-(methyl-alpha-D-glucopyranosid-2-yl)-1-nitrosoureas.
    Morikawa T; Takeda M; Arai Y; Tsujihara K
    Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2386-92. PubMed ID: 7139813
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative studies on anti-tumor effects of nitrosoureas, ACNU and MCNU, on experimental brain tumors (author's transl)].
    Harada K; Kiya K; Okamoto H; Uozumi T
    Neurol Med Chir (Tokyo); 1981 Oct; 21(10):1017-23. PubMed ID: 6172720
    [No Abstract]   [Full Text] [Related]  

  • 8. TCNU: a ray of hope for designer nitrosoureas?
    Workman P
    Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1823-8. PubMed ID: 3325292
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitor of DNA polymerase in sera of tumour-bearing mice.
    Gottlieb AA; Smith AH; Plescia OJ; Persico FJ; Nicholson DE
    Nature; 1973 Dec 21-28; 246(5434):480-2. PubMed ID: 4128412
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of ionising radiation and chemical methylation upon the activity and accuracy of E. COLI DNA polymerase I.
    Saffhill R
    Biochem Biophys Res Commun; 1974 Nov; 61(2):802-8. PubMed ID: 4616694
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of the nitrosoureas as a function of their lipid solubility in the chemotherapy of experimental rat brain tumors.
    Levin VA; Kabra P
    Cancer Chemother Rep; 1974; 58(6):787-92. PubMed ID: 4447922
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative structure-activity relationships in anticancer agents. Activity of selected nitrosoureas against a solid tumor, the Lewis lung carcinoma.
    Montgomery JA; Mayo JG
    J Med Chem; 1974 May; 17(5):477-80. PubMed ID: 4830248
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo enhancement of the experimental oncostatic effect of RFCNU by its encapsulation in liposomes.
    Mathé G; Bothorel P
    Biomedicine; 1981 Dec; 35(7-8):201-2. PubMed ID: 7346064
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.
    Hayat M; Bourut C; Chenu E; Montero JL; Imbach JL; MacDonald JS; Mathé G
    Cancer Chemother Pharmacol; 1979; 3(4):217-21. PubMed ID: 161207
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of nitrosoureas under development in Japan.
    Ogawa M; Fujimoto S
    Recent Results Cancer Res; 1981; 76():115-24. PubMed ID: 6453413
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Barker M; Hoshino T; Gurcay O; Wilson CB; Nielsen SL; Downie R; Eliason J
    Cancer Res; 1973 May; 33(5):976-86. PubMed ID: 4703128
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of isocyanates in the toxicity of antitumour haloalkylnitrosoureas.
    Gibson NW; Hickman JA
    Biochem Pharmacol; 1982 Sep; 31(17):2795-800. PubMed ID: 7138575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
    Akaike Y; Arai Y; Taguchi H; Satoh H
    Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of N-alkyl-N-nitrosourea on the protein-synthesizing system of liver and hepatoma 22a cells].
    Abakumova OIu; Ugarova TIu; Pilipenko NN; Kutsenko NG; Lerman MI
    Biull Eksp Biol Med; 1973 Oct; 75(10):51-4. PubMed ID: 4360614
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytostatic activity of steroid linked nitrosoureas.
    Zeller WJ; Schreiber J; Ho AD; Schmähl D; Eisenbrand G
    J Cancer Res Clin Oncol; 1984; 108(1):164-8. PubMed ID: 6746709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.